<DOC>
	<DOCNO>NCT02194257</DOCNO>
	<brief_summary>Study determine basic pharmacokinetics ambroxol [ 14C ] -radioactivity include mass balance , excretion pathway complete metabolism healthy male volunteer follow administration lozenge 20 mg ambroxol together oral solution 0.4 mg [ 14C ] -ambroxol label two different position</brief_summary>
	<brief_title>Investigation Metabolism Pharmacokinetics Ambroxol Healthy Male Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Ambroxol</mesh_term>
	<criteria>Healthy male accord follow criterion : Based upon complete medical history , include physical examination , vital sign ( Blood Pressure ( BP ) , Pulse Rate ( PR ) ) , 12lead Electrocardiogram ( ECG ) , clinical laboratory test Age ≥18 ≤65 year Body mass index ( BMI ) ≥18.5 BMI ≤29.9 kg/m2 Signed date write informed consent prior admission study accordance Good Clinical Practice ( GCP ) local legislation Any finding medical examination ( include BP , PR ECG ) deviate normal clinical relevance Any evidence clinically relevant concomitant disease Gastrointestinal , hepatic , renal , respiratory , cardiovascular , metabolic , immunological hormonal disorder Diseases central nervous system ( epilepsy ) psychiatric disorder neurological disorder History relevant orthostatic hypotension , faint spell blackouts Chronic relevant acute infection History relevant allergy/hypersensitivity ( include allergy study drug excipients ) Intake drug long halflife ( &gt; 24 hour ) within least one month less ten halflives respective drug prior administration trial Use drug might reasonably influence result trial base knowledge time protocol preparation within ten day prior administration last sample Visit 2 collect Participation another trial investigational drug within two month prior administration trial Smoker ( &gt; 10 cigarette &gt; 3 cigar &gt; 3 pipes/day ) Inability refrain smoke stay trial centre Alcohol abuse ( average two unit alcoholic beverage per day 14 unit per week ( one unit equal one pint [ 285 mL ] beer lager , one glass [ 125 mL ] wine , 25 mL shoot 40 % spirit ) ) . Drug abuse Blood donation ( 100 mL within 60 day prior study drug administration trial ) Excessive physical activity ( within one week prior administration Trial followup examination ) Any laboratory value outside reference range clinical relevance Inability comply dietary regimen study centre A marked baseline prolongation QT/QTc interval ( e.g. , repeated demonstration QTc interval &gt; 450 m ) Exclusion criterion specific study : Veins unsuitable blood sample PR interval &gt; 220 m QRS interval &gt; 120 m Exposure radiation diagnostic reason ( except dental Xrays plain Xrays thorax bony skeleton [ exclude spinal column ] ) , work participation medical trial previous year Irregular defecation pattern ( less per two day )</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2014</verification_date>
</DOC>